Dr. Tal Zacks, who serves as the medical director of Moderna will join the board of Teva Pharmaceuticals

Posted on Aug 27, 2021 by Ifi Reporter - Dan Bielski

One of the well-known figures in the field of corona vaccines, Dr. Tal Zacks, who serves as the medical director of Moderna, the pioneer of the vaccine against the virus, who recently announced his intention to retire from the Biomed company at the end of September 2021, will join the board of Teva Pharmaceuticals. 
Zacks will add to the Teva board - which is half manned by Israelis, to further diversify the composition of its members, so that it will include figures from the world of science, business, entrepreneurship and medicine.
Dr. Zacks, 55, burst into the Israeli public consciousness in the summer of 2020, until the start of the vaccine race.
The State of Israel also purchased from the vaccines developed by the company, however, most of the vaccines given in Israel are made by Pfizer.


ABOUT IFI TODAY

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum

Newsline

El Al Appoints Levi Halevi as New CEO; CFO Yaakov Shahar to Retire

Sep 20, 2026 by Ifi Reporter - Dan Bielski

El Al Israel Airlines announced a major leadership transition this afternoon, with the appointment of Levi Halevi as the airline’s new Chief Executive Officer . The decision was made by El Al’s Board of Directors , following the recommendation of a search committee... Continue reading →

Former NBA Star Omri Casspi Raises $250 Million for Third Venture Fund

Sep 4, 2026 by Ifi Reporter - Dan Bielski

Former NBA player Omri Casspi has raised $250 million for the third fund of his venture capital firm, Swish Ventures, marking another major milestone in his transition from professional basketball to the technology investment world. The new fund brings Swish Ventures' total assets... Continue reading →

Why AI Adoption on the Factory Floor Is Far More Complicated Than a Successful Demo

Aug 25, 2026 by Ifi Reporter - Dan Bielski

The integration of artificial intelligence (AI) has become a major priority for technology companies and startups. Yet when AI solutions move from development environments to the physical factory floor, the reality can be considerably more complex.... Continue reading →


Testimonials

No testimonials. Click here to add your testimonials.